Article Details

Melinta Therapeutics and Hikma Sign Exclusive Licensing Agreement for Two Novel Anti-Infectives ...

Retrieved on: 2021-04-29 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Melinta Therapeutics and Hikma Sign Exclusive Licensing Agreement for Two Novel Anti-Infectives .... View article details on hiswai:

Excerpt

The addition of these two innovative products to Hikma's portfolio builds on its hospital anti-infective franchise and provides healthcare professionals ...

Article found on: www.valdostadailytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up